Results 21 to 30 of about 1,482,841 (244)

FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY

open access: yesВестник урологии, 2018
Introduction. Prostate cancer is one of the common oncological diseases in men. Standard prostate biopsy with subsequent histological verification is now an integral part of the diagnosis of prostate cancer; however, the number of false-negative results ...
A. A. Keln   +6 more
doaj   +1 more source

Report of results of pleural biopsy (Needle biopsy and open biopsy) in 108 cases and 245 biopsies [PDF]

open access: yes, 1960
1. The results of 245 pleural biopsies perfomed in 108 patients including 219 pleural needle biopsies and 26 pleural open biopsies were reported. The method of pleural biopsy seems to be superior to any other currently available diagnostic procedures for
Sohn, Isaack, Mc, Lt. Col.
core   +1 more source

Biopsy confirmation of metastatic sites in breast cancer patients:clinical impact and future perspectives [PDF]

open access: yes, 2014
Determination of hormone receptor (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor 2 status in the primary tumor is clinically relevant to define breast cancer subtypes, clinical outcome, and the choice of therapy.
Carmen Criscitiello   +38 more
core   +2 more sources

Do not underestimate anterior prostate cancer

open access: yesBiomedical Papers, 2021
Aims. With the introduction of magnetic resonance imaging in the diagnosis of prostate cancer and its use in targeted prostate biopsy, an increased incidence of anterior-predominant prostate cancer (APC) has been observed. Methods.
Sarka Kudlackova   +5 more
doaj   +1 more source

Developments in MRI-targeted prostate biopsy [PDF]

open access: yes, 2020
PURPOSE OF REVIEW: MRI-targeted prostate biopsy may be an attractive alternative to systematic biopsy for diagnosing clinically significant prostate cancer.
Walz, J   +5 more
core   +1 more source

The Utility and Limitations of Contrast-Enhanced Ultrasound for the Diagnosis and Treatment of Prostate Cancer

open access: yesSensors, 2015
In association with the widespread use of prostate specific antigen (PSA) screening, the numbers of men identified with early-stage prostate cancer (PCa) are increasing in the developed countries, including Japan.
Futoshi Sano, Hiroji Uemura
doaj   +1 more source

Complication Rates After TRUS Guided Transrectal Systematic and MRI-Targeted Prostate Biopsies in a High-Risk Region for Antibiotic Resistances

open access: yesFrontiers in Surgery, 2020
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for prostate biopsies is associated with higher (infectious) complications rates compared to transperineal biopsies.
Mike Wenzel   +16 more
doaj   +1 more source

HistoScanningTM vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods

open access: yesВестник урологии, 2023
Introduction. Prostate cancer (PCa) is one of the most common malignant diseases. The prostate biopsy is the verification standard of PCa. The multifocal biopsy under ultrasound (US) guidance shows high rate of false negative results.
S. V. Kotov   +8 more
doaj   +1 more source

The Effect of Targeted Antibiotic Prophylaxis on Lower Urinary Tract Symptoms Following Prostate Biopsy: A Prospective Randomized Trial [PDF]

open access: yes, 2023
Objective:Targeted antibiotic prophylaxis in prostate biopsy is recommended for patients at risk due to increased complication rates seen in recent years.
Abdullah Çırakoğlu   +5 more
core   +1 more source

Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients

open access: yesProstate Cancer, 2021
Objective. The study investigates the prostate-specific antigen threshold for adding targeted, software-based, magnetic resonance imaging-ultrasound fusion biopsy during a standard 12-core biopsy in biopsy-naïve patients.
Luke L. Wang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy